Arkolith/Insider Trading/BCRX/Form 4

Barnes Alane P

Chief Legal OfficerBIOCRYST PHARMACEUTICALS INC (BCRX) · full profile →Form 4 · filed Dec 23, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$167K
Net Open-Market Flow
-$167K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 22, 2025Sell(S)22K$7.65$167K399K
Dec 19, 2025Tax withholding(F)17K$7.41$125K421K

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000882796-25-000043) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML